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Pregnancy associated osteoporosis 
– a case report
Osteoporoza związana z ciążą – opis przypadku
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Katedra i Zakład Medycyny Rodzinnej, 
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Polska
 Abstract
Loss of bone mineral density (BMD) – usually temporary – occurs during pregnancy and lactation. Pregnancy 
associated osteoporosis (PAO) is an uncommon disease of unknown etiology. We present a case of a 35-year old 
woman with PAO, manifesting initially at the end of the first pregnancy as back pain. It reappeared in the second 
pregnancy, four years later. X-ray revealed multilevel compression fractures of Th12, L1, L2. DEXA showed L2-L4 
T-score: -3.3 SD, hip T-score: -2.09 SD. Laboratory findings were irrelevant. She was put on antiresorptive treatment, 
calcium and vitamin D. Although there has been an improvement in BMD, the patient is a definite candidate for 
vertebral kyphoplasty due to disabling pain.
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 Streszczenie
W czasie ciąży i laktacji dochodzi do utraty gęstości masy kostnej, jednak najczęściej jest ona przejściowa. Os-
teoporoza związana z ciążą (pregnancy associated osteoporosis – PAO) jest rzadką chorobą o nieznanej etiologii. 
Prezentujemy przypadek 35-letniej kobiety, u której choroba manifestowała się początkowo pod koniec pierwszej 
ciąży bólem pleców. Pojawiły się one także w drugiej ciąży, cztery lata później. Rtg ujawniło wielopoziomowe złama-
nia kompresyjne Th12, L1, L2. Densytometria wykazała T- score L2-L4: -3,3 SD, T-score z bliższego końca kości 
udowej: -2,09 SD. Wyniki badań laboratoryjnych nie wykazały istotnych patologii. Chora została poddana leczeniu 
przeciwresorpcyjnemu, preparatami wapnia i witaminy D. Mimo, że nastąpiła poprawa w zakresie parametrów 
densytometrycznych, ból w dalszym ciągu znacznie upośledza życie pacjentki i powoduje, że jest ona kandydatką 
do vertebroplastyki.
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Introduction 
Osteoporosis	 is	 a	disease	of	 an	old	 age,	most	prevalent	 in	
postmenopausal	 women.	 Pregnancy	 associated	 osteoporosis	
(PAO)	 is	 a	 rare	 condition	 of	 unknown	 etiology.	 Since	 the	 first	
report	 in	 1948,	 about	 100	 cases	 have	 been	 described	 [1].	 It	
manifests	generally	in	primiparas	at	the	end	of	pregnancy	or	in	

















spine	 substantially	 intensified.	 Neurological	 examination	 was	
unremarkable	 with	 no	 focal	 signs.	 The	 pregnancy	 ended	 in	
cesarean	section	(healthy	male,	birthweight	3250	g).	The	woman	
was	 hospitalized	 at	 the	 Department	 of	 Neurology.	 The	 X-ray	
showed	 multilevel	 fractures	 of	 Th12,	 L1,	 L2.	 Osteoporosis	
complicated	by	compression	vertebral	fractures	was	diagnosed.	
Laboratory	 tests	 revealed	 serum	 levels	 of	 calcium,	 alkaline	
phosphatase	and	parathyroid	hormone	 to	be	normal,	phosphate	
excretion	in	the	urine	was	slightly	reduced.	
In	 2001,	 patient’s	 height	 was	 162	 cm	 (2-cm	 defect	 in	
comparison	to	the	pre-pregnancy	height).	Subsequently,	she	was	
discouraged	 from	 lactation,	 provided	with	 the	 Javette’s	 corset,	
treated	with	salmon	calcitonin	nasal,	alfacalcidol	and	NSAIDs,	









–		distal	 forearm	 BMD:	 0.250g/cm²,	 T-score:	 -3.48	 SD,	
Z-score:	-3.48	SD.
MRI	 of	 the	 spine	 performed	 3	 months	 after	 the	 delivery	
confirmed	compression	fracture	of	Th8	and	L1	and	infraction	of	
upper	epiphyseal	plate	of	10th,	11th	and	12th	 thoracic	vertebrae.	
Neither	 neoplastic	 invasion	 nor	 compression	 of	 the	 spinal	
cord	 were	 found.	 The	 patient	 was	 recommended	 therapy	 with	
antifracture	 medications	 accompanied	 by	 supplementation	













Physical	 examination	 in	 2011	 revealed	 –	 height	 161	 cm,	
weight	62	kg;	pain	on	palpation	and	limitation	of	movement	of	
thoracic	and	lumbar	spine,	painful	tension	of	paraspinal	muscles.	
No	 abnormalities	 were	 found	 on	 neurological	 examination.	
Medication	 taken	 a	 the	 time	 were:	 risedronate	 35	 mg/week,	
alfacalcidol	1	mg/day,	calcium	carbonate	400mg/day.	Periodically,	






the	patient	was	 referred	 to	MRI,	 (Figure	1),	which	showed	 the	
deepening	 of	 the	 vertebral	 upper	 and	 lower	 lamina	 from	 Th8	
to	L1.	The	greatest	changes	occurred	in	the	vertebral	bodies	of	
Th8	 and	 L1,	 where	 codfish	 appearance	 was	 seen.	 Intrathecal	
movements	were	not	demonstrated.	Adjacent	intervertebral	discs	
revealed	 signs	 of	 degenerative	 changes	 -	 reduction	 in	 height	
(except	for	Th12/L1	and	L1/L2),	presence	of	small	gas	bubbles	
(vacuum	symptom)	and	discrete	bulging	of	fibrous	rings.	Slight	
compression	 of	 the	 anterior	 part	 of	 the	 dural	 sack	 was	 seen.	
Visualized	spinal	cord	and	cauda	equina	roots	were	normal.	
Current	 BMD:	 L2-L4	 -	 0.971	 g/cm²,	 T-score:	 -1.91	 SD,	
Z-score:	-1.77	SD.
Figure 1. MRI of the thoraco-lumbar spine. Codfish appearance of Th8 and L1. 
Discrete bulging of fibrous rings.
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Parity	 and	 lactation	 –	 contrary	 to	 popular	 opinions	 –	 do	
not	 contribute	 to	 permanent	 deterioration	 of	 BMD.	 The	 fact	
remains	 that	 there	 are	 changes	 in	 the	 calcium	 metabolism	






current	 data	 show	 that	 after	weaning	BMD	 returns	 to	 baseline	
within	 6-12	 months	 [5].	 Such	 condition	 corresponds	 with	 the	
concept	of	transient	osteoporosis	of	pregnancy	(TOP)	[6].	
Moreover,	most	 of	 the	 studies	 report	 lack	 of	 difference	 in	
both	 BMD	 and	 incidence	 of	 osteoporosis	 in	 later	 life	 among	
women	who	were	pregnant	at	least	once	and	nulliparas	[7].	The	
former	were	 shown	 to	 have	 3-5%	 higher	BMD	 than	 the	 latter	
[8].	Large	clinical	studies	–	SOF	[9],	MEDOS	[10],	EVOS	[11]	
-	 reported	 the	same	incidence	of	fractures	 in	women	who	gave	
birth	and	nulliparas.














period	 that	 followed	 vertebral	 fractures	 in	 course	 of	 PAO	 and	















are	 no	 established	 treatment	 protocols	 and	 long-term	 effects	
of	 such	 therapy.	 Women	 usually	 benefit	 from	 treatment	 with	
bisphosphonates	and	calcitonine.	There	were	also	some	reports	
about	 cases	 of	 strontium	 ranelate	 therapy	 [1].	 Some	 authors	
reported	that	in	women	with	PAO	treated	with	bisphosphonates,	
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